Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-003615
Filing Date
2025-02-11
Accepted
2025-02-11 17:43:17
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 form4-02112025_100214.html 4  
1 form4-02112025_100214.xml 4 4187
  Complete submission text file 0001415889-25-003615.txt   5760
Mailing Address C/O APPLIED DNA SCIENCES, INC. 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790
Business Address
Ryan Charles S. (Reporting) CIK: 0001624830 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 25611083

Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)